Inhaled therapeutics for prevention and treatment of pneumonia

Author： Safdar Amar Shelburne Samuel A Evans Scott E Dickey Burton F

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.8, Iss.4, 2009-07, pp. : 435-449

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aerosolised Antibacterials for the Prevention and Treatment of Hospital-Acquired Pneumonia

By Wood G. Christopher Swanson Joseph M.

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 903-914

Adis International

Access to resources Recommend Favorite

Inhaled Antibiotics for Nosocomial Pneumonia

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 2, 2012-04 ,pp. : 116-123

Bentham Science Publishers

Access to resources Recommend Favorite

Inhaled corticosteroids increase pneumonia risk in COPD

Reactions Weekly, Vol. 1, Iss. 1231, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Inhaled corticosteroids increase pneumonia risk in COPD

Inpharma, Vol. 1, Iss. 1667, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Surprising results link inhaled corticosteroids and pneumonia

Inpharma, Vol. 1, Iss. 1598, 2007-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite